Pharmacotherapy of preterm labor

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Maternal-Fetal Medicine

Background:

• The physiological triggers of human parturition are complex and not fully understood.
• Assessing the risk and severity of preterm labor presents significant clinical challenges.
• Comparing the efficacy of different tocolytic agents is difficult due to varied study criteria.

Purpose of the Study:

• To review physiological factors initiating birth.
• To examine challenges in managing preterm labor.
• To discuss pharmacotherapeutic agents for preterm labor treatment.

Main Methods:

• Review of physiological factors and clinical challenges in parturition.
• Analysis of pharmacotherapeutic agents used for tocolysis.
• Discussion of beta-2-sympathomimetics, calcium channel blockers, magnesium sulfate, and other agents.

Main Results:

• Beta-2-sympathomimetics (betamimetics) are effective for short-term and long-term tocolysis by influencing myometrial calcium.
• Ritodrine is FDA-approved, while terbutaline is effective and less expensive.
• Other agents like nifedipine, verapamil, magnesium sulfate, indomethacin, and aspirin are also discussed.

Conclusions:

• Individualized pharmacotherapy based on patient condition and side effects is essential.
• Selective beta-2 sympathomimetics, such as terbutaline or ritodrine, remain the most valuable agents for inhibiting preterm labor.